A recent study demonstrated that two clinically approved drugs, decitabine and gemcitabine have potent anti-HIV activity in cell culture when used alone or in combination [1].
Based on gemcitabine's potency and lack of toxicity, the data suggest that gemcitabine may be a clinically relevant alternative to hydroxyurea for the treatment of retroviral infections.